Compare Novavax Inc (NVAX) vs Materials Select Sector SPDR Fund (XLB) Price & Performance
Price performance (Past 24H)
Key statistics
Key statistics
Novavax Inc vs Materials Select Sector SPDR Fund — how do they compare? Novavax Inc trades at $8.11 (market cap $1.30B), while Materials Select Sector SPDR Fund trades at $50.64. The key difference: Materials Select Sector SPDR Fund is trading nearer its 52-week high, Novavax Inc nearer its low. Which is the better fit depends on your goals.
| NVAX | XLB | |
|---|---|---|
Market Cap | $1.30B | — |
Sector | Health | — |
52-Week High | $11.19 | $53.62 |
52-Week Low | $6.22 | $42.23 |
Enterprise Value | $800.50M | — |
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
Novavax (NVAX) trades at $8.08, down 1.64% on the day, with a bearish technical signal but strong recent earnings beats. The company reported $1.12B revenue in 2025 with a net income of $440.30M, though 2026 projections show a return to losses. Analyst consensus is bullish with a $14.00 price target, but negative shareholder equity and cash flow concerns persist.
Outlook remains mixed: strong valuation ratios and analyst support suggest upside potential, but negative cash flows, high liabilities, and projected 2026 losses pose significant risks. Investor sentiment is cautious amid recent stock declines and shareholder dissent highlighted in recent news.
XLB trades at $50.03, down 0.99% with a bearish technical signal from moving averages. The materials ETF faces mixed sentiment as recent news highlights sector opportunities from infrastructure trends and geopolitical supply chain shifts, though some analysts caution on valuation after recent gains. Support levels cluster around $49-50 while resistance sits at $51.
Outlook remains cautious with technical weakness offset by structural demand drivers. Key risks include geopolitical sensitivity and cyclical pricing pressure, while potential exists from manufacturing expansion and critical minerals focus. The neutral oscillator readings suggest limited near-term momentum.
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
Top news
Latest headlines on both assets
Top news
Latest headlines on both assets
About Novavax Inc
Novavax, Inc. is a clinical stage biotechnology company. The Company creates novel vaccines to address a broad range of infectious diseases worldwide using proprietary virus-like particle (VLP) technology.
Read more on NVAX →About Materials Select Sector SPDR Fund
In seeking to track the performance of the index, the fund employs a replication strategy. It generally invests substantially all, but at least 95%, of its total assets in the securities comprising the index. The index includes securities of companies from the following industries: chemicals; metals and mining; paper and forest products; containers and packaging; and construction materials. The fund is non-diversified.
Read more on XLB →
